Accepted industry practice for new drug products includes consignment or initial stocking up to target outlets at liberal credit terms, or through an inventory financing scheme.
Inventory financing schemes are often employed, where payment is based on actual units consumed and subsequent stock replenishments (based on what has been sold or moved out).
New ethical drug products are typically introduced to (PDPA):
Physicians
Dentists
Pharmacists
Allied professionals
Promotional efforts include (SBLOPS):
Sampling
Detailing through brochures and leaflets
Other promotional paraphernalia
Conducting product symposia
Aim is to gain support, patronage, and commitment from prescribers and endorsers.